Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210033605 210013387 1.7 58.6 Disease modification (D) 2017-04-12 2017-10-08 CARBOPLATIN + ETOPOSIDE N N 210040419 BEVACIZUMAB
210033606 210031489 1.65 82.6 Curative (C) null 2013-11-22 UKALL XII Maintenance (3 months) Y N 210040494 METHOTREXATE HIGH DOSE
210033607 210013397 0 45 Curative (C) 2019-11-03 2019-11-03 Erwinase (Erwinia Asparaginase) N N 210040510 CHOP
210033608 210013401 1.9 82.5 null 2014-01-08 2014-01-15 UKALL XII Intensification N N 210040523 ERWINIA ASPARAGINASE
210033609 210013415 0 null Palliative (P) null 2016-10-11 CARBOPLATIN + VINCRISTINE N N 210040618 CARBOPLATIN + VINCRISTINE
210033610 210013417 null 64 Curative (C) 2017-10-22 2017-10-29 Methotrexate High Dose (3g/m2) null Y 210040628 RIALTO TRIAL
210033611 210022420 1.17 86 Curative (C) 2017-03-08 2017-03-15 Bendamustine +/- Prednisolone N N 210040696 CARBOPLATIN + ETOPOSIDE
210033612 210013432 null null null 2016-09-14 2016-09-19 CHOP - 21 days 02 N 210040696 CARBOPLATIN + ETOPOSIDE
210033613 210013440 1.72 null Disease modification (D) 2013-08-11 2014-01-13 CARBOPLATIN + ETOPOSIDE N N 210040728 CARBOPLATIN + ETOPOSIDE
210033614 210013459 null null Disease modification (D) 2018-01-12 2018-01-12 Inotuzumab Ozogamicin N N 210040847 IDELALISIB
210033615 210022435 0 16 Adjuvant (A) 2017-12-22 2019-03-17 Methotrexate High Dose (3g/m2) N N 210040871 METHOTREXATE HIGH DOSE
210033616 210013466 null 13.7 Palliative (P) 2013-09-17 2016-01-26 Erwinase (Erwinia Asparaginase) Y null 210040880 CYCLOPHOSPHAMIDE + VINCRISTINE
210033617 210013469 1.87 29.2 Palliative (P) 2017-04-18 2017-04-21 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE N N 210040886 CARBOPLATIN + ETOPOSIDE + VINCRISTINE
210033618 210013477 null 62 Curative (C) 2013-07-28 2015-09-12 CARBOPLATIN + VINORELBINE N null 210040931 BEVACIZUMAB + TEMOZOLOMIDE
210033619 210013481 1.7 null Adjuvant (A) 2018-03-25 2018-03-26 Vinorelbine (oral) Y N 210040958 PACKER MAINTENANCE
210033620 210013490 1.87 null Curative (C) 2018-02-07 2018-03-06 ICE-R Y N 210041016 CVD
210033621 210013491 1.54 39.2 null null 2014-07-27 ALL Int Guide B Int Maint Ph III N Y 210041021 LOMUSTINE + PROCARBAZINE + VINCRISTINE
210033622 210013497 1.83 90.75 Curative (C) 2018-03-24 2018-11-12 Ofatumumab Loading Y N 210041034 ICE-R
210033623 210013506 1.65 74.3 Palliative (P) 2016-08-16 2016-08-21 CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine Y N 210041101 TAMIGA TRIAL
210033624 210022459 1.8 70 null 2016-05-19 2016-05-19 Abiraterone N N 210041115 BEVACIZUMAB + LOMUSTINE
210033625 210013512 null 52 Curative (C) 2015-04-24 2015-04-24 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE Y N 210041122 TRASTUZUMAB EMTANSINE
210033626 210013518 null 77.7 Curative (C) null 2017-11-18 IRINOTECAN + TEMOZOLOMIDE N N 210041191 POMALIDOMIDE
210033627 210013522 1.56 63.05 null 2018-01-25 2018-03-12 CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE Y N 210041193 BEVACIZUMAB + TEMOZOLOMIDE
210033628 210013527 1.75 88.4 Curative (C) 2019-02-25 2019-02-25 Bevacizumab + Temozolomide Y N 210041199 BR14 TRIAL
210033629 210013531 null 72 Curative (C) null 2014-10-27 CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine Y N 210041244 BEVACIZUMAB + LOMUSTINE
210033630 210013547 1.75 73 Curative (C) 2015-07-04 2016-03-06 MELPHALAN N N 210041346 SIOP
210033631 210022475 1.6 null Curative (C) 2016-11-09 2016-11-09 Docetaxel 75mg/m2 (21 day) 02 N 210041357 BEVACIZUMAB + TEMOZOLOMIDE
210033632 210013562 1.8 70.7 Neo-adjuvant (N) 2014-09-30 2014-11-07 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N null 210041423 BEVACIZUMAB + TEMOZOLOMIDE
210033633 210033674 null 50 Curative (C) 2015-08-13 2015-11-08 MELPHALAN N null 210041470 BEVACIZUMAB + TEMOZOLOMIDE
210033634 210038358 1.76 null Curative (C) null 2013-11-07 Cytarabine intrathecal Y N 210041615 TAMIGA TRIAL
210033635 210013590 1.6 null Adjuvant (A) 2015-07-20 2016-09-21 Alemtuzumab+Busulfan+CyclophosphMUD N N 210041618 BEVACIZUMAB + IRINOTECAN
210033636 210013597 null 63 Curative (C) 2012-09-21 2015-07-03 Gemcitabine + Oxaliplatin N N 210041630 GEMCARBO
210033637 210013606 1.65 82.3 Curative (C) 2017-03-14 2017-04-07 Irinotecan + Temozolomide N N 210041679 BEVACIZUMAB + IRINOTECAN
210033638 210028109 1.66 66.5 Curative (C) null 2018-09-12 REGORAFENIB N N 210041701 BEVACIZUMAB + TEMOZOLOMIDE
210033639 210013614 null null Palliative (P) 2014-03-27 2014-03-29 CYTARABINE + ETOPOSIDE 02 N 210041789 IRINOTECAN + TEMOZOLOMIDE
210033640 210013615 1.57 60.7 Curative (C) 2014-08-11 2014-08-13 Pemetrexed 02 N 210041797 FEC
210033641 210013622 1.72 null Curative (C) 2019-05-09 2019-05-22 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE 02 N 210041817 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE
210033642 210013629 0 63.7 null 2016-03-22 2016-03-23 DAUNORUBICIN + VINCRISTINE Y N 210041854 IRINOTECAN + TEMOZOLOMIDE
210033643 210013631 1.7 70 Curative (C) 2016-01-27 2016-02-10 Bortezomib (weekly) N N 210041861 CARBOPLATIN + PROCARBAZINE
210033644 210028119 1.66 65.2 Curative (C) null 2015-04-26 FLAG 99 N 210041872 CARBOPLATIN + ETOPOSIDE + VINCRISTINE
210033645 210013641 1.75 41.4 Curative (C) 2015-12-23 2015-12-30 Docetaxel 75mg/m2 (21 day) N N 210041947 IRINOTECAN + TEMOZOLOMIDE
210033646 210013644 1.73 null null 2018-02-28 2018-03-20 Cytarabine HD + Methotrexate HD N null 210041983 CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE
210033647 210028126 null null Curative (C) 2015-02-06 2015-05-14 Irinotecan + Temozolomide N null 210042033 DACTINOMYCIN + CYCLO + VINCRISTINE
210033648 210022530 null 99.8 Palliative (P) null 2015-07-15 Trastuzumab emtansine (Kadcyla) 1st 0 null 210042066 HYDROXYCARBAMIDE
210033649 210022531 1.61 0 Palliative (P) 2015-04-07 2016-09-09 Bevacizumab + Irinotecan Y N 210042069 CARBO + ETOPOSIDE + VINCRISTINE
210033650 210022533 1.58 58.3 Palliative (P) null 2017-10-28 DA N null 210042072 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE
210033651 210013663 1.7 78 Palliative (P) 2016-02-10 2016-10-26 Hydroxycarbamide Y N 210042133 RCEOP
210033652 210013667 1.57 66.6 Palliative (P) 2018-03-02 2018-03-07 MELPHALAN N N 210042147 UKALL 60+ TRIAL
210033653 210013672 1.6 null Curative (C) 2017-02-25 2017-03-02 Hydroxycarbamide Y N 210042169 FLUDARABINE
210033654 210013673 1.79 null Curative (C) 2018-12-05 2018-12-05 CVP R + GEMCITABINE N N 210000284 FMD